Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Implant endosseous root-form

XiVE S plus Impl D3.8/L13: medical device reports filed with FDA

2,321 reports name it, 2019–2026. Manufacturer given most often on reports: Dentsply Implants Manufacturing. Product code DZE.

2,321
device reports naming the brand
0% of all MAUDE reports · about 328 a year
182
reports, 12 months to August 2026
299 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 2,321 reports that name the brand "XiVE S plus Impl D3.8/L13" (implant endosseous root-form), received between June 2019 and August 2026; the manufacturer given most often on reports is Dentsply Implants Manufacturing. Spellings of one product vary from report to report.

182 reports arrived in the 12 months to August 2026, down 39% from 299 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are osseointegration problem (36.6%), failure to osseointegrate (31.5%) and loss of osseointegration (24.6%). The patient problems coded most often are failure of implant, inflammation and osteolysis. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

02448Sep 2021: 15Oct 2021: 38Nov 2021: 29Dec 2021: 432022Jan 2022: 40Feb 2022: 31Mar 2022: 44Apr 2022: 33May 2022: 45Jun 2022: 30Jul 2022: 35Aug 2022: 37Sep 2022: 29Oct 2022: 24Nov 2022: 43Dec 2022: 322023Jan 2023: 33Feb 2023: 32Mar 2023: 31Apr 2023: 42May 2023: 39Jun 2023: 34Jul 2023: 34Aug 2023: 32Sep 2023: 31Oct 2023: 28Nov 2023: 48Dec 2023: 282024Jan 2024: 24Feb 2024: 36Mar 2024: 28Apr 2024: 28May 2024: 35Jun 2024: 24Jul 2024: 29Aug 2024: 28Sep 2024: 30Oct 2024: 36Nov 2024: 22Dec 2024: 122025Jan 2025: 25Feb 2025: 23Mar 2025: 41Apr 2025: 18May 2025: 17Jun 2025: 21Jul 2025: 37Aug 2025: 17Sep 2025: 16Oct 2025: 16Nov 2025: 13Dec 2025: 152026Jan 2026: 27Feb 2026: 19Mar 2026: 14Apr 2026: 14May 2026: 13Jun 2026: 15Jul 2026: 10Aug 2026: 10

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

03567122019: 6120192021: 71220212022: 42320222023: 41220232024: 33220242025: 25920252026: 1222026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%2,321
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%2,321
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Osseointegration problem85036.6%7.7%
Failure to osseointegrate73131.5%62.8%
Loss of osseointegration57124.6%22.4%
Fracturea broken bone1657.1%1.6%
Damaged thread40.2%0%
Crackthe device cracked20.1%0%
Off-label use20.1%0%
Malposition of device10%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant2,31799.8%
Inflammationinflammation28412.2%
Osteolysis1416.1%
Pocket erosion1255.4%
Implant pain80.3%
Painpain, site not specified60.3%
Fistula20.1%
Inadequate osseointegration10%
Infiltration into tissue10%
Sinus perforation10%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureXiVE S plus Impl D3.8/L13Product code DZEAll MAUDE reports
Reports2,3213,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer100%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about XiVE S plus Impl D3.8/L13 reports

How many FDA reports name XiVE S plus Impl D3.8/L13?

2,321 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 182 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

osseointegration problem (36.6%), failure to osseointegrate (31.5%), loss of osseointegration (24.6%), fracture (7.1%) and damaged thread (0.2%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that XiVE S plus Impl D3.8/L13 was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.